Matthew S Block

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Endometrial Cancer

Advanced Non Small Cell Lung Cancer

Electronic Health Record

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO clinical cancer informatics

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah Barman, Sriram Venkateswaran, Antonio Del Santo, Unice Yoo, Eli Silvert, Krishna Rao, Bharathwaj Raghunathan, Lisa A Kottschade, Matthew S Block, G Scott Chandler, Joshua Zalis, Tyler E Wagner, Rajat Mohindra
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing. JCO clinical cancer informatics 8 (2024)
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Elsbernd, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliams, Andrea E Wahner Hendrickson, John S Weroha, Yiyi Yan, Joel M Reid, Svetomir N Markovic, Matthew S Block
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (12) (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Hannah Barman, Sriram Venkateswaran, Antonio Del Santo, Unice Yoo, Eli Silvert, Krishna Rao, Bharathwaj Raghunathan, Lisa A Kottschade, Matthew S Block, G Scott Chandler, Joshua Zalis, Tyler E Wagner, Rajat Mohindra
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing. JCO clinical cancer informatics 8 (2024)
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Elsbernd, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliams, Andrea E Wahner Hendrickson, John S Weroha, Yiyi Yan, Joel M Reid, Svetomir N Markovic, Matthew S Block
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (12) (2024)
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Elsbernd, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliams, Andrea E Wahner Hendrickson, John S Weroha, Yiyi Yan, Joel M Reid, Svetomir N Markovic, Matthew S Block
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (12) (2024)
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Elsbernd, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliams, Andrea E Wahner Hendrickson, John S Weroha, Yiyi Yan, Joel M Reid, Svetomir N Markovic, Matthew S Block
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (12) (2024)
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Elsbernd, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliams, Andrea E Wahner Hendrickson, John S Weroha, Yiyi Yan, Joel M Reid, Svetomir N Markovic, Matthew S Block
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (12) (2024)
Hannah Barman, Sriram Venkateswaran, Antonio Del Santo, Unice Yoo, Eli Silvert, Krishna Rao, Bharathwaj Raghunathan, Lisa A Kottschade, Matthew S Block, G Scott Chandler, Joshua Zalis, Tyler E Wagner, Rajat Mohindra
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing. JCO clinical cancer informatics 8 (2024)
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Elsbernd, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliams, Andrea E Wahner Hendrickson, John S Weroha, Yiyi Yan, Joel M Reid, Svetomir N Markovic, Matthew S Block
A Phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Hannah Barman, Sriram Venkateswaran, Antonio Del Santo, Unice Yoo, Eli Silvert, Krishna Rao, Bharathwaj Raghunathan, Lisa A Kottschade, Matthew S Block, G Scott Chandler, Joshua Zalis, Tyler E Wagner, Rajat Mohindra
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing. JCO clinical cancer informatics 8 (2024)
Lisa A Kottschade, Gregory Russell Pond, Anthony J Olszanski, Yousef Zakharia, Evidio Domingo-Musibay, Ralph J Hauke, Brendan D Curti, Sarah Schober, Mohammed M Milhem, Matthew S Block, Tina J Hieken, Robert R McWilliams
SALVO: Single Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Chen Wang, Matthew S Block, Julie M Cunningham, Mark E Sherman, Bryan M McCauley, Sebastian M Armasu, Robert A Vierkant, Nadia Traficante, null null, Aline Talhouk, Susan J Ramus, Nadja Pejovic, Martin Koebel, Brooke D Jorgensen, Dale W Garsed, Sian Fereday, Jennifer Anne Doherty, Dinuka Ariyaratne, Michael S Anglesio, Martin Widschwendter, Tanja Pejovic, Jesus Gonzalez Bosquet, David D L Bowtell, Stacey J Winham, Ellen L Goode
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Upasana Ray, Prabhu Thirusangu, Ling Jin, Yinan Xiao, Christopher L Pathoulas, Julie K Staub, Courtney L Erskine, Keith Dredge, Edward Hammond, Matthew S Block, Scott H Kaufmann, Jamie N Bakkum-Gamez, Viji Shridhar
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction. Oncogene (2023)
Haley E Mudrick, Shane Massey, Erin B McGlinch, Brian J Parrett, Jack R Hemsath, Mary E Barry, Jeffrey D Rubin, Chisom Uzendu, Michael J Hansen, Courtney L Erskine, Virginia P Van Keulen, Aleksandra Drelich, Joseph A Panos, Madiha Fida, Gina A Suh, Tobias Peikert, Matthew S Block, Chien-Te Kent Tseng, Gloria R Olivier, Michael A Barry
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2. Science advances 8 (34) (2022)
Tommaso Grassi, Faye R Harris, James B Smadbeck, Stephen J Murphy, Matthew S Block, Francesco Multinu, Janet L Schaefer Klein, Piyan Zhang, Giannoula Karagouga, Minetta C Liu, Alyssa Larish, Maureen A Lemens, Marla Kay S Sommerfield, Serena Cappuccio, John C Cheville, George Vasmatzis, Andrea Mariani
Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer. PloS one 16 (6) (2021)
Matthew S Block, Allan B Dietz, Michael P Gustafson, Kimberly R Kalli, Courtney L Erskine, Bahaaeldin Youssef, Geraldine V Vijay, Jacob B Allred, Kevin D Pavelko, Michael A Strausbauch, Yi Lin, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Andrea E Wahner-Hendrickson, S John Weroha, Gretchen E Glaser, Amanika Kumar, Carrie L Langstraat, Mary L Solseth, Michael C Deeds, Keith L Knutson, Martin J Cannon
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients. Nature communications 11 (1) (2020)
Thomas T DeLeon, Daniel R Almquist, Benjamin R Kipp, Blake T Langlais, Aaron R Mangold, Jennifer L Winters, Heidi E Kosiorek, Richard W Joseph, Roxana S Dronca, Matthew S Block, Robert R McWilliams, Lisa A Kottschade, Kandelaria M Rumilla, Jesse S Voss, Mahesh Seetharam, Aleksandar Sekulic, Svetomir N Markovic, Alan H Bryce
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations. PloS one 15 (3) (2020)
Eric P Grewal, Courtney L Erskine, Wendy K Nevala, Jacob B Allred, Carrie A Strand, Lisa A Kottschade, Robert R McWilliams, Roxana S Dronca, Adam J Yakovich, Svetomir N Markovic, Matthew S Block
Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanoma. Immunotherapy 12 (13) (2020)
Yuan-Ping Pang, Laura R Elsbernd, Matthew S Block, Svetomir N Markovic
Peptide-Binding Groove Contraction Linked to the Lack of T Cell Response: Using Complex Structure and Energy To Identify Neoantigens. ImmunoHorizons 2 (7) (2018)